BioLineRx Ltd. (NASDAQ/TASE: BLRX) is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The company’s first approved product is APHEXDA® (motixafortide) with an indication in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma. BioLineRx is advancing a pipeline of investigational medicines for patients with sickle cell disease, pancreatic cancer, and other solid tumors. Headquartered in Israel, and with operations in the U.S., the company is driving innovative therapeutics with end-to-end expertise in development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.

Learn more about who we are, what we do, and how we do it at www.biolinerx.com, or on Twitter and LinkedIn.  

Invus is a global equity investment firm with an evergreen capital structure, operating out of offices in the U.S., Europe and Asia. Since its founding in 1985, Invus has focused on empowering entrepreneurs and entrepreneurial teams to transform their industries across both public and private equity investments.

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. For more information, visit https://guardanthealth.com/

Leading scientists and researchers turn to Flywheel to accelerate their work and collaborate with ease. Our medical imaging AI platform streamlines the massive tasks of data discovery, aggregation, and curation; automates research workflows; and scales on demand. For more information, visit https://flywheel.io/.

As a global company WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through our unique business models, our integrated, end-to-end services help customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. For more information visit www.advancedtherapies.com.

Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development. With deep therapeutic and regulatory expertise and an expansive global footprint across the Asia-Pacific region, North America, and Europe, Novotech offers clients an accelerated path to bring life-changing therapies to market. For more information, please visit https://novotech-cro.com/ 

Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

The PPD clinical research business of Thermo Fisher Scientific enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. For more information, please visit https://www.thermofisher.com/ppd

Grand River Aseptic Manufacturing, Inc. (“GRAM”) is a leading contract development and manufacturing organization with advanced equipment and innovative technology that delivers customized solutions to meet clients’ fill and finish needs for liquid vials, lyophilized vials, syringes, and cartridges. With biologic, small molecule, and vaccine capabilities, Grand River Aseptic Manufacturing supports pharmaceutical development, cGMP manufacturing, analytical testing, and regulatory filing. To learn more, please visit https://www.grandriverasepticmfg.com/

PredxBio is a TechBio company, headquartered in Pittsburgh, harnessing the power of spatial biology to unravel the hidden circuitries of the tumor microenvironment and getting to the “Why?” of cancer. Demonstrating a clear impact today, we have established an impressive accuracy in predicting patient responses to immunotherapy across the most critical cancers. Our ground-breaking platform aims to transform cancer care with next generation spatial analytics and explainable AI, thereby accelerating advancements in drug development and clinical trials. PredxBio opens a new era with far-reaching implications for biomarker discovery and clinical research with promising results in understanding disease progression and response to therapy. For more information please reach us at info@predxbio.com

The Sanner Group is a global Contract Development and Manufacturing Organization (CDMO), dedicated to delivering high-quality, finished drug delivery devices for its customers. With over 750 employees and cutting-edge manufacturing facilities across the EU, US, and China, Sanner Group excels in turning complex medical device projects into reality. Their expertise extends across a wide range of critical drug delivery systems, such as autoinjectors, infusion pumps, inhalers, safety syringes, and connected devices. The company's innovative approach to device design and development is further strengthened by its Design Centres of Excellence in the US (Gilero) and UK (Springboard), which drive cutting-edge solutions for customers. For more information, visit https://www.sanner-group.com/

Alcanza Clinical Research is an integrated network of research facilities dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations. These facilities are strategically located across the Southeast, Northeast, and Midwest regions of the United States. Alcanza supports studies in all trial phases and major therapeutic areas. To learn more, please visit https://alcanzaclinical.com/